top of page
  • Facebook
  • Twitter
  • Instagram
Wint Headshot_edited.jpg

Dylan Wint, MD
Medical Director
Cleveland Clinic Nevada

New Hope in the Treatment of Dementia
Saturday, February 13, 2027
9:00 AM - 10:00 AM

Dylan Wint joined Cleveland Clinic in 2015, and currently serves as Medical Director of Cleveland Clinic Nevada. He is also Director of Education and stewards the Camille and Larry Ruvo Chair for Brain Health and the Las Vegas Legacy Chair for Neuroscience Education. He was educated at Stanford University, The University of Miami, The University of Florida, and the National Institutes of Health. 


 

He is board-certified in Psychiatry, Neurology, and Behavioral Neurology/Neuropsychiatry. He strives to be worthy of the patience, sacrifices, and support of God, family, mentors, colleagues, students, patients, and research participants by working to reduce human suffering.

Lecture Summary:

This presentation will review recent advances in the diagnosis and treatment of common dementias, with particular attention to biomarker testing, in vivo detection of disease pathology, and emerging disease-modifying therapies. The session will examine how dementia biomarkers can inform diagnosis and clinical decision-making, as well as which patients may be appropriate candidates for anti-amyloid treatment. The presentation will also address the potential benefits, risks, and practical burdens of these therapies to help psychiatrists make informed treatment decisions and appropriate referrals.

​Goals and Learning Objectives:

  • At the end of this presentation, attendees will be able to identify patients who may benefit from anti-amyloid treatmen

  • At the end of this presentation, attendees will know the indications and interpretations of dementia biomarker testing

  • At the end of this presentation, attendees will know the benefits and burdens of anti-amyloid treatments​

​

Disclosures:

Consultant : Biogen Inc; Eli Lilly
Speakers' Bureau or Honoraria : Acadia past

bottom of page